SHR-3821
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SHR-3821, covering 2025-11-17 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study [Phase 2]